Cargando…

Validation of CD98hc as a Therapeutic Target for a Combination of Radiation and Immunotherapies in Head and Neck Squamous Cell Carcinoma

SIMPLE SUMMARY: The outcome of patients with locally advanced head and neck squamous cell carcinoma (HNSCC) has not changed for the past decade despite advances in treatment strategies. SLC3A2, which encodes CD98hc, was identified as a putative biomarker for HNSCC radioresistance. Chimeric antigen r...

Descripción completa

Detalles Bibliográficos
Autores principales:	Köseer, Ayşe Sedef, Loureiro, Liliana R., Jureczek, Justyna, Mitwasi, Nicola, González Soto, Karla Elizabeth, Aepler, Julia, Bartsch, Tabea, Feldmann, Anja, Kunz-Schughart, Leoni A., Linge, Annett, Krause, Mechthild, Bachmann, Michael, Arndt, Claudia, Dubrovska, Anna
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8997111/ https://www.ncbi.nlm.nih.gov/pubmed/35406454 http://dx.doi.org/10.3390/cancers14071677

Ejemplares similares

UniCAR T cell immunotherapy enables efficient elimination of radioresistant cancer cells
por: Arndt, Claudia, et al.
Publicado: (2020)

Immunotargeting of Cancer Stem Cells
por: Köseer, Ayse Sedef, et al.
Publicado: (2023)

Highly Efficient Targeting of EGFR-Expressing Tumor Cells with UniCAR T Cells via Target Modules Based on Cetuximab(®)
por: Jureczek, Justyna, et al.
Publicado: (2020)

Amino Acid Transporters on the Guard of Cell Genome and Epigenome
por: Kahya, Uğur, et al.
Publicado: (2021)

Conditional deletion of CD98hc inhibits osteoclast development
por: Tsumura, Hideki, et al.
Publicado: (2015)

CD98hc is a target for brain delivery of biotherapeutics
por: Chew, Kylie S., et al.
Publicado: (2023)

Tyrosine Kinase c-MET as Therapeutic Target for Radiosensitization of Head and Neck Squamous Cell Carcinomas
por: Lüttich, Lina, et al.
Publicado: (2021)

Efficacy of Beta1 Integrin and EGFR Targeting in Sphere-Forming Human Head and Neck Cancer Cells
por: Zscheppang, Katja, et al.
Publicado: (2016)

Extracellular domain of CD98hc is required for early murine development
por: Sato, Yukiyasu, et al.
Publicado: (2011)

Development of novel target modules for retargeting of UniCAR T cells to GD2 positive tumor cells
por: Mitwasi, Nicola, et al.
Publicado: (2017)

Oct4 confers stemness and radioresistance to head and neck squamous cell carcinoma by regulating the homologous recombination factors PSMC3IP and RAD54L
por: Nathansen, Jacqueline, et al.
Publicado: (2021)

CD98hc facilitates B cell proliferation and adaptive humoral immunity
por: Cantor, Joseph, et al.
Publicado: (2009)

Author Correction: CD98hc is a target for brain delivery of biotherapeutics
por: Chew, Kylie S., et al.
Publicado: (2023)

Dependence of proliferative vascular smooth muscle cells on CD98hc (4F2hc, SLC3A2)
por: Fogelstrand, Per, et al.
Publicado: (2009)

Expression of CD98hc in Pancreatic Cancer and Its Role in Cancer Cell Behavior
por: Bianconi, Daniela, et al.
Publicado: (2022)

An oligo-His-tag of a targeting module does not influence its biodistribution and the retargeting capabilities of UniCAR T cells
por: Jureczek, Justyna, et al.
Publicado: (2019)

Specific requirements for translation of biological research into clinical radiation oncology
por: Krause, Mechthild, et al.
Publicado: (2020)

Targeting Acute Myeloid Leukemia Using the RevCAR Platform: A Programmable, Switchable and Combinatorial Strategy
por: Kittel-Boselli, Enrico, et al.
Publicado: (2021)

CD98hc (SLC3A2) regulation of skin homeostasis wanes with age
por: Boulter, Etienne, et al.
Publicado: (2013)

Cancer stem cell related markers of radioresistance in head and neck squamous cell carcinoma
por: Kurth, Ina, et al.
Publicado: (2015)

Targeting CD10 on B-Cell Leukemia Using the Universal CAR T-Cell Platform (UniCAR)
por: Mitwasi, Nicola, et al.
Publicado: (2022)

CD98 heavy chain as a prognostic biomarker and target for cancer treatment
por: Xia, Pu, et al.
Publicado: (2023)

Efficient Heat Shock Response Affects Hyperthermia-Induced Radiosensitization in a Tumor Spheroid Control Probability Assay
por: Chen, Oleg, et al.
Publicado: (2021)

“UniCAR”-modified off-the-shelf NK-92 cells for targeting of GD2-expressing tumour cells
por: Mitwasi, Nicola, et al.
Publicado: (2020)

Design of a surrogate Anticalin protein directed against CD98hc for preclinical studies in mice
por: Deuschle, Friedrich‐Christian, et al.
Publicado: (2020)

Development of a high affinity Anticalin(®) directed against human CD98hc for theranostic applications
por: Deuschle, Friedrich-Christian, et al.
Publicado: (2020)

Combining Radiation- with Immunotherapy in Prostate Cancer: Influence of Radiation on T Cells
por: Lindner, Diana, et al.
Publicado: (2022)

CD98hc (SLC3A2) participates in fibronectin matrix assembly by mediating integrin signaling
por: Féral, Chloé C., et al.
Publicado: (2007)

CD98hc (SLC3A2) drives integrin-dependent renal cancer cell behavior
por: Poettler, Marina, et al.
Publicado: (2013)

The receptor protein tyrosine phosphatase PTPRJ negatively modulates the CD98hc oncoprotein in lung cancer cells
por: D’Agostino, Sabrina, et al.
Publicado: (2018)

Loss of the branched-chain amino acid transporter CD98hc alters the development of colonic macrophages in mice
por: Wuggenig, Philipp, et al.
Publicado: (2020)

Prognostic values of L-type amino acid transporter 1 and CD98hc expression in breast cancer
por: Ichinoe, Masaaki, et al.
Publicado: (2021)

Surfaceome analyses uncover CD98hc as an antibody drug-conjugate target in triple negative breast cancer
por: Montero, Juan Carlos, et al.
Publicado: (2022)

A Small Step, a Giant Leap: Somatic Hypermutation of a Single Amino Acid Leads to Anti-La Autoreactivity
por: Bartsch, Tabea, et al.
Publicado: (2021)

CD98hc (SLC3A2) sustains amino acid and nucleotide availability for cell cycle progression
por: Cano-Crespo, Sara, et al.
Publicado: (2019)

CD98hc as a marker of radiotherapy-resistant cancer stem cells in head and neck squamous cell carcinoma
por: Kawasaki, Yohei, et al.
Publicado: (2020)

Dual role of ER stress in response to metabolic co-targeting and radiosensitivity in head and neck cancer cells
por: Chen, Oleg, et al.
Publicado: (2020)

CD98hc has a pivotal role in maintaining the immuno-barrier integrity of basal layer cells in esophageal epithelium
por: Ye, Hao, et al.
Publicado: (2022)

Versatile chimeric antigen receptor platform for controllable and combinatorial T cell therapy
por: Feldmann, Anja, et al.
Publicado: (2020)

P98 - Gluten allergy
por: Barrosa Maia, Estefânia, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_49243hrfq9e0g3ep80ged0a3ka